Crescent Biopharma Stock (NASDAQ:CBIO)
Previous Close
$10.97
52W Range
$9.81 - $37.00
50D Avg
$12.83
200D Avg
$15.66
Market Cap
$149.90M
Avg Vol (3M)
$134.37K
Beta
1.34
Div Yield
-
CBIO Company Profile
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.